These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

936 related items for PubMed ID: 34715817

  • 1. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
    Tang W, Xu F, Zhao M, Zhang S.
    BMC Cancer; 2021 Oct 29; 21(1):1160. PubMed ID: 34715817
    [Abstract] [Full Text] [Related]

  • 2. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma.
    Xu F, Zhang Z, Zhao Y, Zhou Y, Pei H, Bai L.
    Gene; 2021 Aug 30; 795():145804. PubMed ID: 34175402
    [Abstract] [Full Text] [Related]

  • 3. Squalene epoxidase promotes breast cancer progression by regulating CCNB1 protein stability.
    Tuluhong D, Gao H, Li X, Wang L, Zhu Y, Xu C, Wang J, Li H, Li Q, Wang S.
    Exp Cell Res; 2023 Dec 01; 433(1):113805. PubMed ID: 37839786
    [Abstract] [Full Text] [Related]

  • 4. Identification and validation of a ferroptosis-related gene signature predictive of prognosis in breast cancer.
    Liu Q, Ma JY, Wu G.
    Aging (Albany NY); 2021 Sep 09; 13(17):21385-21399. PubMed ID: 34499616
    [Abstract] [Full Text] [Related]

  • 5. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y, Tu Z, Lei K, Huang K, Zhu X.
    Biosci Rep; 2021 Dec 22; 41(12):. PubMed ID: 34726238
    [Abstract] [Full Text] [Related]

  • 6. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D, Wei G, Ma J, Cheng S, Jia L, Song X, Zhang M, Ju M, Wang L, Zhao L, Xin S.
    BMC Cancer; 2021 May 31; 21(1):645. PubMed ID: 34059009
    [Abstract] [Full Text] [Related]

  • 7. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F, Guan Y, Ma Y, Xue L, Zhang P, Yang X, Chong T.
    Aging (Albany NY); 2021 Apr 21; 13(8):11919-11941. PubMed ID: 33952721
    [Abstract] [Full Text] [Related]

  • 8. The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi-omics study.
    Xu F, Guan Y, Xue L, Zhang P, Li M, Gao M, Chong T.
    Cancer Med; 2021 Dec 21; 10(24):9078-9096. PubMed ID: 34761566
    [Abstract] [Full Text] [Related]

  • 9. Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro research.
    Bai Z, Xu F, Feng X, Wu Y, Lv J, Shi Y, Pei H.
    Bioengineered; 2022 Jan 21; 13(1):1717-1735. PubMed ID: 35000541
    [Abstract] [Full Text] [Related]

  • 10. Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer.
    Zhong J, Shen X, Zhou J, Yu H, Wang B, Sun J, Wang J, Liu F.
    Front Oncol; 2023 Jan 21; 13():1077342. PubMed ID: 36998462
    [Abstract] [Full Text] [Related]

  • 11. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    He F, Chen Z, Deng W, Zhan T, Huang X, Zheng Y, Yang H.
    Int Immunopharmacol; 2021 Sep 21; 98():107789. PubMed ID: 34130150
    [Abstract] [Full Text] [Related]

  • 12. Integration of Bioinformatics and Machine Learning to Identify CD8+ T Cell-Related Prognostic Signature to Predict Clinical Outcomes and Treatment Response in Breast Cancer Patients.
    Wu B, Li L, Li L, Chen Y, Guan Y, Zhao J.
    Genes (Basel); 2024 Aug 19; 15(8):. PubMed ID: 39202452
    [Abstract] [Full Text] [Related]

  • 13. A novel ferroptosis-related long noncoding RNA signature for relapse free survival prediction in patients with breast cancer.
    Wang Y, Xu Y, Zhang Y.
    Medicine (Baltimore); 2022 Aug 05; 101(31):e29573. PubMed ID: 35945765
    [Abstract] [Full Text] [Related]

  • 14. Machine learning- and WGCNA-mediated double analysis based on genes associated with disulfidptosis, cuproptosis and ferroptosis for the construction and validation of the prognostic model for breast cancer.
    Xu L, Wang S, Zhang D, Wu Y, Shan J, Zhu H, Wang C, Wang Q.
    J Cancer Res Clin Oncol; 2023 Dec 05; 149(18):16511-16523. PubMed ID: 37712959
    [Abstract] [Full Text] [Related]

  • 15. Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma.
    Zhao Y, Song Q, Xu F, Zhou Y, Zuo X, Zhang Z.
    Front Genet; 2022 Dec 05; 13():823443. PubMed ID: 35368686
    [Abstract] [Full Text] [Related]

  • 16. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
    Xu L, Zheng Q, Liu W.
    BMC Cancer; 2022 Mar 02; 22(1):229. PubMed ID: 35236323
    [Abstract] [Full Text] [Related]

  • 17. N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma.
    Zhou K, Yang J, Li X, Xiong W, Zhang P, Zhang X.
    Front Surg; 2022 Mar 02; 9():893977. PubMed ID: 35784919
    [Abstract] [Full Text] [Related]

  • 18. Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer.
    Shen C, Chai W, Han J, Zhang Z, Liu X, Yang S, Wang Y, Wang D, Wan F, Fan Z, Hu H.
    Front Immunol; 2023 Mar 02; 14():1213947. PubMed ID: 37965307
    [Abstract] [Full Text] [Related]

  • 19. Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer.
    Hao S, Yang Z, Wang G, Cai G, Qin Y.
    BMC Cancer; 2024 Aug 06; 24(1):958. PubMed ID: 39107713
    [Abstract] [Full Text] [Related]

  • 20. Identifying subtypes and developing prognostic models based on N6-methyladenosine and immune microenvironment related genes in breast cancer.
    Wang L, Li J, Mei N, Chen H, Niu L, He J, Wang R.
    Sci Rep; 2024 Jul 18; 14(1):16586. PubMed ID: 39020010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.